VORICONAZOLE AS SALVAGE THERAPY IN IMMUNOCOMPROMISED PATIENTS WITH PULMONARY ASPERGILLOSIS WHO RECEIVED FIRST LINEE ANTIFUNGAL THERAPY WITH CASPOFUNGIN

被引:0
|
作者
Simeone, E. [1 ]
Candoni, A. [1 ]
Chiozzotto, M. [1 ]
Fanin, R. [1 ]
机构
[1] Div Hematol, Udine, Italy
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0179
引用
收藏
页码:71 / 71
页数:1
相关论文
共 50 条
  • [21] Caspofungin salvage therapy in a neutropenic patient with probable invasive aspergillosis: a case report.
    F. S. Taccone
    R. Marechal
    N. Meuleman
    M. Aoun
    Supportive Care in Cancer, 2003, 11 : 742 - 744
  • [22] Pediatric antifungal therapy. Part I: focus on febrile neutropenia, invasive aspergillosis, combination antifungal therapy and invasive candidiasis in immunocompromised pediatric patients
    Allen, U.
    Bow, E.
    Doyle, J.
    Richardson, S.
    Robinson, J.
    Rotstein, C.
    Davies, D.
    Hui, C.
    Le Saux, N.
    Laverdiere, M.
    Read, S.
    MINERVA PEDIATRICA, 2010, 62 (01) : 57 - 69
  • [23] Combination therapy with voriconazole and caspofungin for fungal infections in patients with acute leukemia
    Lamanna, N
    Weiss, MA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 616S - 616S
  • [24] Pharmacoeconomic analysis of voriconazole vs. caspofungin in the empirical antifungal therapy of febrile neutropenia in Australia
    Al-Badriyeh, Daoud
    Liew, Danny
    Stewart, Kay
    Kong, David C. M.
    MYCOSES, 2012, 55 (03) : 244 - 256
  • [25] Efficacy and Safety Profile of Voriconazole as Salvage Therapy for Invasive Aspergillosis with Hematologic Diseases in Korea
    Kwon, Jae-Cheol
    Kim, Si-Hyun
    Choi, Su-Mi
    Choi, Jae Ki
    Lee, Dong-Gun
    Park, Sun Hee
    Choi, Jung-Hyun
    Yoo, Jin-Hong
    Shin, Wan-Shik
    INFECTION AND CHEMOTHERAPY, 2010, 42 (01): : 17 - 22
  • [26] The incidence of cutaneous squamous cell carcinoma in patients receiving voriconazole therapy for chronic pulmonary aspergillosis
    Chris Kosmidis
    Anna Mackenzie
    Chris Harris
    Rola Hashad
    Fiona Lynch
    David W. Denning
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2020, 393 : 2233 - 2237
  • [27] The incidence of cutaneous squamous cell carcinoma in patients receiving voriconazole therapy for chronic pulmonary aspergillosis
    Kosmidis, Chris
    Mackenzie, Anna
    Harris, Chris
    Hashad, Rola
    Lynch, Fiona
    Denning, David W.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2020, 393 (11) : 2233 - 2237
  • [28] Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis
    Maertens, Johan
    Glasmacher, Axel
    Herbrecht, Raoul
    Thiebaut, Anne
    Cordonnier, Catherine
    Segal, Brahm H.
    Killar, John
    Taylor, Arlene
    Kartsonis, Nicholas
    Patterson, Thomas F.
    CANCER, 2006, 107 (12) : 2888 - 2897
  • [29] Why immunocompromised patients fail to respond to antifungal therapy?
    Ruhnke, M.
    MYCOSES, 2015, 58 : 11 - 11
  • [30] An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients
    Viscoli, C.
    Herbrecht, R.
    Akan, H.
    Baila, L.
    Sonet, A.
    Gallamini, A.
    Giagounidis, A.
    Marchetti, O.
    Martino, R.
    Meert, L.
    Paesmans, M.
    Ameye, L.
    Shivaprakash, M.
    Ullmann, A. J.
    Maertens, J.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 64 (06) : 1274 - 1281